Kairos Pharma’s Bhowmick presents at Discovery on Target drug discovery conference
Bitget2026/09/23 12:00- Kairos Pharma will participate in the Discovery on Target Drug Discovery Conference in Boston from Sept. 28 to Oct. 1.
- Neil Bhowmick will moderate an in-person breakout, “Winning the Race against Cancer Therapy Resistance,” on Sept. 30.
- Bhowmick will deliver a Sept. 30 main-stage presentation on KROS-101, a GITR-targeting candidate for solid tumors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
IM Cannabis prices US$1.31 million registered direct share offering at US$2 per share
The inflation bill has arrived, and Wall Street is starting to discount the "profit feast" of American companies.
Wall Street analysts have lowered their US stock earnings forecasts for the first time in 23 weeks, ending the longest streak of upward revisions since September 2021. High inflation and rising energy costs are squeezing profit margins in sectors such as consumer, raw materials, and finance. The combination of pressure on corporate earnings (the numerator) and rising discount rates (the denominator) is exposing US stocks to significant valuation adjustment risks.
Rezolve AI Targets $60 Million in Annualized Savings Under Cost Reduction Program; Shares Up Pre-Bell
Crypto prices
More
